Managing AI Investments in the Agentic Era
▶ The 2-minute explainer
Summary
Enterprises can effectively manage AI investments in the agentic era by focusing on measuring useful work per dollar, enhancing efficiency, and scaling high-value workflows.
Why it matters
Leadership and strategy teams need clear frameworks to evaluate and optimize AI spending, ensuring that investments translate into measurable business value and competitive advantage.
How to implement this in your domain
- 1Define clear, measurable KPIs for AI projects, focusing on "useful work per dollar."
- 2Implement robust tracking and reporting mechanisms to monitor AI agent performance and resource consumption.
- 3Conduct regular audits of AI workflows to identify inefficiencies and areas for optimization.
- 4Prioritize AI investments in workflows that offer the highest potential for business impact and scalability.
- 5Develop a cross-functional team to oversee AI strategy, investment, and performance evaluation.
Who benefits
Key takeaways
- Measure AI investment success by "useful work per dollar."
- Focus on improving the efficiency of AI deployments.
- Scale AI applications in high-value workflows for maximum impact.
- Strategic investment management is crucial in the agentic AI era.
Original post by OpenAI News
"Learn how enterprises can manage AI investments in the agentic era by measuring useful work per dollar, improving efficiency, and scaling high-value workflows."
View on XOriginally posted by OpenAI News on X · view source
Want to go deeper?
Turn these trends into skills with Learnijoy's hands-on AI & tech courses.
Explore coursesMore in AI Investing
Next-Gen Consumer Businesses May Monetize Via Data Sales.
The author speculates that future on-demand consumer businesses might achieve sustainable unit economics by selling data, rather than relying primarily on advertising as previous generations did.
Chai Discovery Secures $400M, Deploys with Pharma Giants.
Chai Discovery has successfully deployed its technology with major pharmaceutical companies Eli Lilly, Pfizer, and Novartis, and has secured an additional $400 million in funding. This significant development positions the company at the forefront of medical innovation.

DeepSeek AI Company Prepares for IPO This Year
DeepSeek, an artificial intelligence company, is reportedly preparing to file for an Initial Public Offering (IPO) within the current year. This move indicates the company's intent to go public and seek significant investment.